Answers are grounded in this paper and cite their sources.
Management of benign prostatic hyperplasia (BPH) constitutes a major component of urologic practice. With the rise of remote healthcare from the COVID-19 pandemic, there is a shift in BPH testing to improve accessibility for patients and providers. This study aims to review modern diagnostic tests available for BPH. A literature review was performed with keywords including benign prostatic hyperplasia, lower urinary tract symptoms (LUTS), bladder outlet obstruction, uroflow, urocuff, penile cuff test, digital therapy, mobile health apps, and remote diagnostic and monitoring tools. Inclusion criteria included studies assessing tools for the diagnostic and perioperative work-up of patients with BPH, those assessing flow parameters, and those published within the past 6 years (2020–2026). Multiple methods for remote BPH evaluation exist including questionnaires, remote uroflow, ambulatory urodynamics (UDS), and noninvasive pressure flow studies. Remote questionnaires aid in tracking BPH symptoms but often require technological literacy and are often not validated. Remote uroflow, such as sound-based uroflow and catheter free UDS, allows for multiple data points collected in a more familiar environment but is susceptible to variations in calibration. Ambulatory urodynamics, including Glean UDS, offers a catheter-free alternative to traditional methods. Non-invasive pressure flow studies offer novel ways to measure voiding pressures. Multiple remote and noninvasive tools are emerging in the field of BPH. These tests aim to reduce discomfort, embarrassment, and variability compared to traditional testing. Further studies should be performed to improve validation and standardization of these novel techniques.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: